Botiss Biomaterials Cerabone® Granulate - HSA Registration DE0012075
Access comprehensive regulatory information for Botiss Biomaterials Cerabone® Granulate in the Singapore medical device market through Pure Global AI's free database. This CLASS D medical device is registered under HSA registration number DE0012075 and owned by botiss biomaterials GmbH. The device was registered on January 02, 2013.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
cerabone® Granulate is intended for the permanent filling or reconstruction of aseptic bone defects and for volume augmentation in autologous spongiosa transplantation in dental, oral and maxillofacial surgery. Indications: - Alveolar ridge augmentation/reconstruction - Filling of bone defects (including after root resection, apicoectomy or cystectomy) - Filling of extraction alveoli to support alveolar ridge preservation - Sinus lift procedure - Filling of periodontal bone defects - Filling of extraction sockets as part of immediate implantations - Filling of peri-implant bone defects.